Study identifier:NIS-NES-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Functional assessment of patients with acute bipolar depression after 8 months of follow-up
Bipolar Disorder
-
No
-
All
249
Observational
18 Years - 55 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2012 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This study aims to study prospectively for 8 months a sample of bipolar patients with acute depressive episode in order to identify that factors associated with functional impairment, with especial attention to the presence of subsyndromal symptoms beyond the acute phase.
Location
Location
San Boit de LLobregat, Barcelona, Spain
Location
Valencia, Valencia, Spain
Location
Lerida, Lerida, Spain
Location
Tudela, NAVARRA, Spain
Location
Granollers, Barcelona, Spain
Location
Palencia, Palencia, Spain
Location
Madrid, Madrid, Spain
Location
Sama de Langreo, ASTURIAS, Spain
Arms | Assigned Interventions |
---|---|
1 Diagnosed with bipolar I or II disorder, and with an acute episode of bipolar depression at inclusion | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.